$9.75
3.1647.95%
À la clôture: Sep 1, 5:00 PM EST
$12.91
6.3295.89%
Pré-ouverture: 7:37 AM EST
bioAffinity Technologies (BIAF) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
fiscal year (2025) a publié ses dernières prévisions le $6M - $8M pour bioAffinity Technologies {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-36.00 | $-40.50 | $-40.50 |
| Actual | $-9.60 | $-12.15 | $-16.65 | $-71.10 |
| Surprise | — | +66.3% | +58.9% | -75.6% |
| Revenue | ||||
| Estimate | — | $1.5M | $1.4M | $1.4M |
| Actual | $1.5M | $1.4M | $1.6M | $1.4M |
| Surprise | — | -8.83% | +12.9% | +2.48% |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q1 | May 8, 2026 | $-12.15 | $-36.00 | 66.3 % |
| Q4 | Mar 13, 2026 | $-16.65 | $-40.50 | 58.9 % |
| Q3 | Nov 14, 2025 | $-71.10 | $-40.50 | -75.6 % |
| Q2 | Aug 14, 2025 | $-76.50 | $-45.00 | -70.0 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q1 | May 8, 2026 | $1.35M | $1.48M | -8.83 % |
| Q4 | Mar 13, 2026 | $1.59M | $1.41M | 12.9 % |
| Q3 | Nov 14, 2025 | $1.45M | $1.41M | 2.48 % |
| Q2 | Aug 14, 2025 | $1.27M | $1.51M | -15.7 % |